Key result
Elevated cardiac troponin in acute pulmonary embolism is linked to increased mortality and complications.
Why the study?
Assessment of risk and appropriate management of patients with acute pulmonary embolism remains a challenge, and the role of cardiac troponins I and T in risk stratification requires clarification.
Does elevation of cardiac troponins I and T predict mortality and complicated in-hospital course in patients with acute pulmonary embolism?
Population
106 consecutive patients with confirmed acute pulmonary embolism
Comparison
Patients with elevated cardiac troponins I and T vs patients with normal or moderately elevated levels
Design
Prospective observational study
Follow-up
In-hospital
Authors
Loading...
Troponin elevation was associated with higher mortality in acute PE; supports prognostic use but leaves open therapeutic implications.
Observational (n=106)
Does elevation of cardiac troponins I and T predict mortality and complicated in-hospital course in patients with acute pulmonary embolism?
p-value: P=0.019
High levels of cardiac troponins I and T are strong predictors of in-hospital mortality and complicated clinical course in patients with acute pulmonary embolism.
Konstantinides et al. (2002) conducted an observational in Acute pulmonary embolism (n=106). Cardiac troponins I and T assessment vs. Normal or moderately elevated troponin levels was evaluated on Overall mortality and complicated in-hospital course (p=P=0.019). High levels of cardiac troponin I (>1.5 ng/mL) or T (>0.1 ng/mL) in acute pulmonary embolism significantly increased mortality risk (P=0.019 and P=0.038, respectively) and in-hospital complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: